MedTech Strategist Names HeartSciences as Start-Up to Watch

Artificial Intelligence Improves Frontline Risk Stratification for Heart Diseases

The current screening paradigm for heart disease is missing people at early stages, when diseases are most treatable. HeartSciences has taken a ubiquitous screening tool, the 12-lead ECG, and has, through the application of signal processing and artificial intelligence, turned it into a powerful tool that can detect diastolic dysfunction, an early indicator of most cardiac diseases.

HeartSciences: AI Improves Frontline Risk Sratification for Heart Diseases


0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *